177 related articles for article (PubMed ID: 9366523)
41. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors.
de Boer J; Yeung J; Ellu J; Ramanujachar R; Bornhauser B; Solarska O; Hubank M; Williams O; Brady HJ
Leukemia; 2011 Feb; 25(2):321-30. PubMed ID: 21072044
[TBL] [Abstract][Full Text] [Related]
42. GCN5 acetylates and regulates the stability of the oncoprotein E2A-PBX1 in acute lymphoblastic leukemia.
Holmlund T; Lindberg MJ; Grander D; Wallberg AE
Leukemia; 2013 Mar; 27(3):578-85. PubMed ID: 23044487
[TBL] [Abstract][Full Text] [Related]
43. Role for homodimerization in growth deregulation by E2a fusion proteins.
Bayly R; LeBrun DP
Mol Cell Biol; 2000 Aug; 20(16):5789-96. PubMed ID: 10913162
[TBL] [Abstract][Full Text] [Related]
44. The E2A-HLF oncoprotein activates Groucho-related genes and suppresses Runx1.
Dang J; Inukai T; Kurosawa H; Goi K; Inaba T; Lenny NT; Downing JR; Stifani S; Look AT
Mol Cell Biol; 2001 Sep; 21(17):5935-45. PubMed ID: 11486032
[TBL] [Abstract][Full Text] [Related]
45. The chimeric protein, PEBP2 beta/CBF beta-SMMHC, disorganizes cytoplasmic stress fibers and inhibits transcriptional activation.
Tanaka Y; Fujii M; Hayashi K; Chiba N; Akaishi T; Shineha R; Nishihira T; Satomi S; Ito Y; Watanabe T; Satake M
Oncogene; 1998 Aug; 17(6):699-708. PubMed ID: 9715271
[TBL] [Abstract][Full Text] [Related]
46. DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF.
Hunger SP; Brown R; Cleary ML
Mol Cell Biol; 1994 Sep; 14(9):5986-96. PubMed ID: 8065331
[TBL] [Abstract][Full Text] [Related]
47. The EWS/TEC fusion protein encoded by the t(9;22) chromosomal translocation in human chondrosarcomas is a highly potent transcriptional activator.
Labelle Y; Bussières J; Courjal F; Goldring MB
Oncogene; 1999 May; 18(21):3303-8. PubMed ID: 10359536
[TBL] [Abstract][Full Text] [Related]
48. E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF.
Yoshihara T; Inaba T; Shapiro LH; Kato JY; Look AT
Mol Cell Biol; 1995 Jun; 15(6):3247-55. PubMed ID: 7760820
[TBL] [Abstract][Full Text] [Related]
49. E2A basic helix-loop-helix transcription factors in human leukemia.
LeBrun DP
Front Biosci; 2003 May; 8():s206-22. PubMed ID: 12700034
[TBL] [Abstract][Full Text] [Related]
50. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials.
Kamps MP; Look AT; Baltimore D
Genes Dev; 1991 Mar; 5(3):358-68. PubMed ID: 1672117
[TBL] [Abstract][Full Text] [Related]
51. Oligomeric self-association contributes to E2A-PBX1-mediated oncogenesis.
Lin CH; Wang Z; Duque-Afonso J; Wong SH; Demeter J; Loktev AV; Somervaille TCP; Jackson PK; Cleary ML
Sci Rep; 2019 Mar; 9(1):4915. PubMed ID: 30894657
[TBL] [Abstract][Full Text] [Related]
52. Specific immunologic recognition of the tumor-specific E2A-PBX1 fusion-point antigen in t(1;19)-positive pre-B cells.
Berendes P; Hoogeveen A; van Dijk M; van Denderen J; van Ewijk W
Leukemia; 1995 Aug; 9(8):1321-7. PubMed ID: 7643619
[TBL] [Abstract][Full Text] [Related]
53. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
[TBL] [Abstract][Full Text] [Related]
54. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A/HLF translocation.
Newcombe K; Glassco T; Mueller C
Biochem Biophys Res Commun; 1998 Apr; 245(2):633-9. PubMed ID: 9571207
[TBL] [Abstract][Full Text] [Related]
55. A molecular pathogenesis for transcription factor associated poly-alanine tract expansions.
Albrecht AN; Kornak U; Böddrich A; Süring K; Robinson PN; Stiege AC; Lurz R; Stricker S; Wanker EE; Mundlos S
Hum Mol Genet; 2004 Oct; 13(20):2351-9. PubMed ID: 15333588
[TBL] [Abstract][Full Text] [Related]
56. E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia.
Pi WC; Wang J; Shimada M; Lin JW; Geng H; Lee YL; Lu R; Li D; Wang GG; Roeder RG; Chen WY
Blood; 2020 Jul; 136(1):11-23. PubMed ID: 32276273
[TBL] [Abstract][Full Text] [Related]
57. Oncogenic HoxB7 requires TALE cofactors and is inactivated by a dominant-negative Pbx1 mutant in a cell-specific manner.
Fernandez LC; Errico MC; Bottero L; Penkov D; Resnati M; Blasi F; Caré A
Cancer Lett; 2008 Aug; 266(2):144-55. PubMed ID: 18378073
[TBL] [Abstract][Full Text] [Related]
58. Essential role for the dimerization domain of NuMA-RARalpha in its oncogenic activities and localization to NuMA sites within the nucleus.
Dong S; Qiu J; Stenoien DL; Brinkley WR; Mancini MA; Tweardy DJ
Oncogene; 2003 Feb; 22(6):858-68. PubMed ID: 12584566
[TBL] [Abstract][Full Text] [Related]
59. PBX1 intracellular localization is independent of MEIS1 in epithelial cells of the developing female genital tract.
Dintilhac A; Bihan R; Guerrier D; Deschamps S; Bougerie H; Watrin T; Bonnec G; Pellerin I
Int J Dev Biol; 2005; 49(7):851-8. PubMed ID: 16172981
[TBL] [Abstract][Full Text] [Related]
60. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
Hunger SP; Ohyashiki K; Toyama K; Cleary ML
Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
